Latest news with #robotictechnology
Yahoo
2 days ago
- Business
- Yahoo
Medical Exoskeleton Market Poised for Growth, Estimated to Hit USD 2,267.2 Million by 2032
The Medical Exoskeleton Market presents strong opportunities due to growing demand for rehabilitation solutions, rising spinal cord injury cases, advances in robotic technology, and increased adoption in elderly care and physical therapy settings Burlingame, CA, July 02, 2025 (GLOBE NEWSWIRE) -- The Global Medical Exoskeleton Market is estimated to be valued at USD 538.4 Mn in 2025 and is expected to reach USD 2,267.2 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 22.8% from 2025 to 2032. Medical exoskeletons are wearable systems designed to support movement and enhance physical strength. These devices assist individuals with mobility challenges such as muscle weakness or spinal injuries in walking, standing, lifting, and participating in rehabilitation or work-related tasks. Market growth is fueled by the rising number of spinal cord injuries, increasing orthopaedic conditions, and the expanding elderly population. Request Sample Report: Global Medical Exoskeleton Market Key Takeaways According to Coherent Market Insights (CMI), the global medical skeleton market size is expected to grow more than fourfold, from USD 538.4 Mn in 2025 to USD 2,267.2 Mn by 2032. Global demand for medical exoskeletons is anticipated to increase at a prolific CAGR of 22.8% during the forecast period. Based on type, lower body exoskeletons segment is expected to dominate the industry, holding a market share of 43.2% in 2025. North America is projected to account for nearly two-fifths of the global medical exoskeleton market share in 2025. Europe medical exoskeleton market is estimated to be valued at around USD 150. 75 Mn by 2025. Asia Pacific is poised to record fastest growth during the assessment period. This is due to rising incidence of mobility impairments and disabilities, as well as increasing acceptance and adoption of medical exoskeletons. Get Instant Access! Purchase Research Report and Receive a 25% Discount: Rising Prevalence of Disabilities and Neurological Disorders Fueling Market Growth Coherent Market Insights' latest global medical exoskeleton market research report provides insights into key factors driving the industry's growth. One such key growth driver is the increasing incidence of neurological disorders and physical disabilities. According to the World Health Organization (WHO), over 3 billion people worldwide are living with a neurological condition. This rise in neurological disorders like stroke, multiple sclerosis, Parkinson's disease, and cerebral palsy is expected to boost demand for medical exoskeletons. Medical exoskeletons are designed to assist or enhance human movement. They have the tendency to support rehabilitation by assisting weakened muscles. These wearable mechanical devices consist of structural components, control systems, sensors, motors, and actuators that work together to mimic human motion. High Cost and Regulatory Hurdles Limiting Market Growth The global medical exoskeleton market outlook indicates strong future growth. However, high cost of medical exoskeletons and regulatory challenges are expected to limit market expansion to some extent. Advanced medical exoskeletons are quite expensive, costing thousands of dollars. This high cost deters patients with disabilities from opting for medical exoskeletons, leading to reduced market demand. Similarly, medical exoskeletons must undergo rigorous and often lengthy regulatory approval processes. These processes can delay product launches and increase development costs, potentially hindering the global medical exoskeleton market growth. Ongoing Innovations Creating Lucrative Growth Opportunities Innovation remains a prime area of focus for medical exoskeleton companies to capitalize on emerging opportunities. Leading industry players are constantly integrating AI, IoT, sensors, and lightweight materials in their products to enhance functionality, comfort, and adaptability of medical exoskeletons. Similarly, advancements in battery technologies and wearable designs are making medical exoskeletons more attractive, accessible, and user-friendly. These innovations are expected to play a key role in boosting the overall global medical exoskeleton market value during the forecast period. Impact of AI on the Global Medical Exoskeleton Market Artificial intelligence (AI) is creating strides in the global medical exoskeleton market. This advanced technology is transforming rigid assistive devices into adaptive, intelligent companions. AI enables exoskeletons to anticipate users' intentions as well as deliver real-time motion adjustments and reduce fall risk. This heightened responsiveness is particularly beneficial in rehabilitation. AI-enabled remote monitoring and cloud integration allow clinicians to track progress and adjust protocols virtually. This technology helps extend rehabilitation and mobility support beyond traditional healthcare settings, thereby unlocking new growth opportunities in the medical exoskeleton market. Emerging Global Medical Exoskeleton Market Trends Increasing geriatric population is expected to uplift demand for medical exoskeletons, as older adults are more susceptible to mobility impairments and musculoskeletal conditions like osteoporosis and arthritis. This demographic shift is increasing the need for effective rehabilitation solutions and mobility assistance technologies. Rising cases of spinal cord injuries is positively impacting sales of medical exoskeletons. As more people suffer from spinal cord injuries, they need assistive and rehabilitative technologies like medical exoskeletons. These technologies play a crucial role in supporting mobility, enhancing rehabilitation outcomes, and improving quality of life for individuals with spinal cord injuries. There is a rapid transition from stationary exoskeletons to mobile ones. Companies are striving to develop mobile medical exoskeletons to meet evolving needs and preferences of end users. Leading companies are also focusing on developing exoskeletons for home care settings. This will likely contribute to the expansion of the global medical exoskeleton industry in the coming years. Get Customization on this Report: Analyst's View said Manisha Vibhute, a senior analyst at CMI. Current Events and Their Impact on the Global Medical Exoskeleton Market Event Description and Impact U.S. Department of Veterans Affairs Expands Exoskeleton Coverage Description: The U.S. Department of Veterans Affairs has expanded reimbursement eligibility for powered exoskeletons used in spinal cord injury rehabilitation. Impact: This move is expected to open a significant reimbursement pathway, increasing accessibility for U.S. veterans and encouraging wider adoption of exoskeletons in hospitals and rehabilitation centers. Breakthroughs in Exoskeleton Technologies Description: In February 2025, Chulalongkorn University introduced its 'Exoskeleton Wheelchair,' a hybrid robotic suit designed to assist elderly individuals and people with mobility challenges in sitting, standing, and walking. Impact: Such technological advancements are likely to accelerate innovation and fuel market growth in the medical exoskeleton industry. European Union's AI Act Implementation Begins Description: The EU started phased enforcement of the AI Act, with medical AI-powered devices classified under strict regulatory scrutiny. Impact: Companies developing AI-integrated exoskeletons must comply with rigorous transparency and safety criteria. Competitor Insights Key companies listed in the global medical exoskeleton market report: BIONIK ReWalk Robotics Ekso Bionics Suit X PARKER HANNIFIN CORP Rex Bionics Ltd B-Temia CYBERDYNE INC. ExoAtlet Wandercraft Key Developments In April 2025, Lifeward Ltd. announced the U.S. launch of the ReWalk 7 Personal Exoskeleton for people with spinal cord injuries. The new device, featuring enhanced features, is designed to provide a more functional and personalized walking experience. In February 2025, Wandercraft initiated a new clinical trial for its groundbreaking Personal Exoskeleton at the James J. Peters VA Medical Center in the Bronx, NY. It is the world's first self-balancing exoskeleton developed for personal use. In December 2024, researchers at the Korea Advanced Institute of Science and Technology developed a lightweight wearing robot for paraplegic patients. The new Iron Man Robot, named WalkON Suit F1, can approach paraplegic patients and lock itself onto them, enabling them to walk, climb staircases, and maneuver obstacles. Global Medical Exoskeleton Market Segmentation: By Type Lower Body Exoskeletons Upper Body Exoskeletons Full Body Exoskeletons Others (Soft Exoskeletons, Active Exoskeletons, Passive Exoskeletons) By Mobility Mobile Exoskeletons Stationary Exoskeletons Fixed Exoskeletons By End User Rehabilitation Centers Hospitals Long Term Care Centers Homecare Settings Others (Industrial Sites, Military) By Region North America Europe Asia Pacific Latin America Middle East and Africa Read More Reports: Bionic Prosthetics Market Size, Share & Trend Analysis Report (2025-2032)Exoskeleton Market Size, Share, Trends & Opportunities for 2025 to 2032Military Exoskeleton Market Analysis and Forecast for 2025-2032 Our Trusted Partners:Worldwide Market Reports, Coherent MI, Stratagem Market InsightsGet Recent News: CONTACT: About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Contact Us: Mr. Shah Coherent Market Insights 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States US: + 12524771362 UK: +442039578553 AUS: +61-2-4786-0457 India: +91-848-285-0837 Email: sales@ Website: For Latest Update Follow Us: LinkedIn | Facebook | Twitter
BBC News
29-05-2025
- Health
- BBC News
Enlarged prostate: Robotic technology treatment brings hope
Difficulty peeing, a frequent need to go to the toilet and trouble emptying their bladder - those are just some of the problems living with an enlarged prostate can bring ask David Fleming, from east Belfast, who has been living with one for a number of years and was one of about 1,000 men on a waiting list for bladder outlet left untreated, an enlarged prostate can lead to more severe symptoms such as acute urinary retention and infections - which is why getting that waiting list down is so a new treatment - or more specifically, a new robotic technology - is offering hope that those men can be treated sooner rather than later. Mr Fleming himself was delighted to be one of the first to undergo aquablation therapy at the Ulster treatment, the first of its kind across the island of Ireland, is a minimally-invasive procedure that uses a heat-free waterjet to remove excess prostate tissue, which Mr Fleming said will make a big difference to his life. The 64-year-old's condition, also known as benign prostatic hyperplasia (BPH), worsened early this year and his difficulties peeing led to a catheter being fitted. But this new treatment will "sort the prostate out so that the flow will be good in the future".Mr Fleming said his condition was being managed by medication until December but then it "took on a life of its own"."I would have been waking every hour at night, every hour and a half, so I really wasn't getting much sleep and was really quite tired," he the procedure should solve the issue, ensure the catheter is removed and give him "a good quality of life in relation to what I've had previously". Mr Fleming hopes, come his 65th birthday in September, he will be "a new man". How does aquablation therapy work? While there are several benign prostate treatments available, this treatment particularly helps men experiencing urinary problems due to an enlarged now, men with a very enlarged prostate had to travel to England for treatment or have more complex or invasive surgery in Northern this robotic technology eliminates the need for invasive prostate uses image-guided, high-velocity water jets to precisely remove excess prostate ultrasound imaging helps the surgeon map and direct the water jet with accuracy, avoiding damage to nearby nerves and structures responsible for sexual function and traditional procedures, no heat is involved, significantly lowering the risk of South Eastern Health Trust said this technology reduces the likelihood of side effects such as erectile dysfunction, incontinence and bleeding that may require also offers a shorter recovery time, shorter hospital stays and lower retreatment rates, improving outcomes for patients. What could the new treatment do for NI waiting lists? Ajay Pahuja, consultant urologist at the South Eastern Health Trust, described it as "an exciting new transformative technology" with many benefits for men who have difficulty passing urine."It's quite precise, it's safe and quite quick," he said. "Secondly, we'll be able to probably get patients back to work - an early return to their normal jobs."The complication rates are quite low if you're precise."Mr Pahuja said it also preserves sexual function, which is one of the big things this technology TURP is considered the gold standard care for treating benign prostate (BPH), surgeons say aquablation therapy complements the existing technologies they have and will hopefully help tackle the long waiting Pahuja said the urology waiting list, like other specialities, had a legacy of problems and that those with age-related benign prostate enlargement were waiting "as long as five to seven years" for treatment, with many having to go to said aquablation therapy could mean more efficient and effective treatment, coupled with the South Eastern Health Trust being declared as a regional BPH centre, should help shorten the waiting lists. The trust's assistant director of surgery, Katharine Dane, said all men across Northern Ireland will benefit from this new said aquablation therapy was "a real coup" for the trust. "It just completes the suite of treatment," she on a waiting list in other trusts will be transferred to the Ulster Hospital to be offered this service, if that is what is decided is appropriate for their prostate.
